Skip to content

Press Release · Press Releases · Middle East

OncoHost to Present New Research on Early Detection of Immunotherapy Resistance Using Plasma Proteomics at ISLB 2026

Issued by PR Newswire

New data demonstrates the potential of longitudinal plasma proteomics to detect disease progression ahead of radiologic assessment and predict overall survival in advanced NSCLC BINYAMINA, Israel and CARY, N.C., Nov. 5, 2026 /PRNewswire/ -- OncoHost, a technology company transforming...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories